South Korea · Delayed Price · Currency is KRW SD Biosensor Statistics
Total Valuation
SD Biosensor has a market cap or net worth of KRW 1.25 trillion. The enterprise value is 1.09 trillion.
| Market Cap | 1.25T |
| Enterprise Value | 1.09T |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
SD Biosensor has 119.62 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 119.62M |
| Shares Outstanding | 119.62M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 32.26% |
| Owned by Institutions (%) | 2.68% |
| Float | 32.34M |
Valuation Ratios
The trailing PE ratio is 6.69.
| PE Ratio | 6.69 |
| Forward PE | n/a |
| PS Ratio | 1.77 |
| PB Ratio | 0.41 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | 3.62 |
| P/OCF Ratio | 3.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.55, with an EV/FCF ratio of 3.17.
| EV / Earnings | 5.80 |
| EV / Sales | 1.55 |
| EV / EBITDA | 14.55 |
| EV / EBIT | n/a |
| EV / FCF | 3.17 |
Financial Position
The company has a current ratio of 7.52, with a Debt / Equity ratio of 0.20.
| Current Ratio | 7.52 |
| Quick Ratio | 5.57 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 8.01 |
| Debt / FCF | 1.74 |
| Interest Coverage | -0.92 |
Financial Efficiency
Return on equity (ROE) is 6.29% and return on invested capital (ROIC) is -1.15%.
| Return on Equity (ROE) | 6.29% |
| Return on Assets (ROA) | -1.05% |
| Return on Invested Capital (ROIC) | -1.15% |
| Return on Capital Employed (ROCE) | -1.73% |
| Revenue Per Employee | 1.22B |
| Profits Per Employee | 326.39M |
| Employee Count | 576 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 1.62 |
Taxes
| Income Tax | -458.76B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.39% in the last 52 weeks. The beta is 0.89, so SD Biosensor's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | +10.39% |
| 50-Day Moving Average | 10,155.00 |
| 200-Day Moving Average | 10,406.85 |
| Relative Strength Index (RSI) | 58.01 |
| Average Volume (20 Days) | 122,913 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SD Biosensor had revenue of KRW 702.55 billion and earned 188.00 billion in profits. Earnings per share was 1,555.30.
| Revenue | 702.55B |
| Gross Profit | 339.16B |
| Operating Income | -64.93B |
| Pretax Income | -271.41B |
| Net Income | 188.00B |
| EBITDA | 74.65B |
| EBIT | -64.93B |
| Earnings Per Share (EPS) | 1,555.30 |
Balance Sheet
The company has 761.11 billion in cash and 597.57 billion in debt, giving a net cash position of 163.54 billion or 1,367.21 per share.
| Cash & Cash Equivalents | 761.11B |
| Total Debt | 597.57B |
| Net Cash | 163.54B |
| Net Cash Per Share | 1,367.21 |
| Equity (Book Value) | 3.03T |
| Book Value Per Share | 25,269.41 |
| Working Capital | 1.05T |
Cash Flow
In the last 12 months, operating cash flow was 415.70 billion and capital expenditures -71.53 billion, giving a free cash flow of 344.18 billion.
| Operating Cash Flow | 415.70B |
| Capital Expenditures | -71.53B |
| Free Cash Flow | 344.18B |
| FCF Per Share | 2,877.27 |
Margins
Gross margin is 48.28%, with operating and profit margins of -9.24% and 26.76%.
| Gross Margin | 48.28% |
| Operating Margin | -9.24% |
| Pretax Margin | -38.63% |
| Profit Margin | 26.76% |
| EBITDA Margin | 10.63% |
| EBIT Margin | -9.24% |
| FCF Margin | 48.99% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 1.97%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 1.97% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 12.86% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 1.95% |
| Earnings Yield | 15.10% |
| FCF Yield | 27.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SD Biosensor has an Altman Z-Score of 2.07 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.07 |
| Piotroski F-Score | 6 |